Naqu Area Pioneer Pharma Co., Ltd. - Net Worth and Insider Trading

Naqu Area Pioneer Pharma Co., Ltd. Net Worth

The estimated net worth of Naqu Area Pioneer Pharma Co., Ltd. is at least $48 dollars as of 2024-09-21. Naqu Area Pioneer Pharma Co., Ltd. is the 10% Owner of NovaBay Pharmaceuticals Inc and owns about 65 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $48. Details can be seen in Naqu Area Pioneer Pharma Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Naqu Area Pioneer Pharma Co., Ltd. has not made any transactions after 2012-10-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Naqu Area Pioneer Pharma Co., Ltd.

To

Naqu Area Pioneer Pharma Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Naqu Area Pioneer Pharma Co., Ltd. owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Naqu Area Pioneer Pharma Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Naqu Area Pioneer Pharma Co., Ltd.

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2012-10-31 10 percent owner

Naqu Area Pioneer Pharma Co., Ltd. Latest Holdings Summary

Naqu Area Pioneer Pharma Co., Ltd. currently owns a total of 1 stock. Naqu Area Pioneer Pharma Co., Ltd. owns 65 shares of NovaBay Pharmaceuticals Inc (NBY) as of October 31, 2012, with a value of $48.

Latest Holdings of Naqu Area Pioneer Pharma Co., Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBY NovaBay Pharmaceuticals Inc 2012-10-31 65 0.74 48

Holding Weightings of Naqu Area Pioneer Pharma Co., Ltd.


Naqu Area Pioneer Pharma Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Naqu Area Pioneer Pharma Co., Ltd. has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 39 shares on October 31, 2012, which cost Naqu Area Pioneer Pharma Co., Ltd. around $2 Million.

Insider Trading History of Naqu Area Pioneer Pharma Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Naqu Area Pioneer Pharma Co., Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Naqu Area Pioneer Pharma Co., Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Naqu Area Pioneer Pharma Co., Ltd. is -5.3%. GuruFocus also compares Naqu Area Pioneer Pharma Co., Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Naqu Area Pioneer Pharma Co., Ltd. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Naqu Area Pioneer Pharma Co., Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Naqu Area Pioneer Pharma Co., Ltd.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.64 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.36 LIMIT LIMIT LIMIT LIMIT LIMIT

Naqu Area Pioneer Pharma Co., Ltd. Ownership Network

Ownership Network List of Naqu Area Pioneer Pharma Co., Ltd.

No Data

Ownership Network Relation of Naqu Area Pioneer Pharma Co., Ltd.

Insider Network Chart

Naqu Area Pioneer Pharma Co., Ltd. Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Naqu Area Pioneer Pharma Co., Ltd. is the 10 percent owner of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Naqu Area Pioneer Pharma Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Naqu Area Pioneer Pharma Co., Ltd.. You might contact Naqu Area Pioneer Pharma Co., Ltd. via mailing address: No. 100 Wang Qiao Road, Pudong Area, Shanghai F4 201201.

Discussions on Naqu Area Pioneer Pharma Co., Ltd.

No discussions yet.